Treatment of idiopathic pulmonary fibrosis: a network meta-analysis

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease associated with high morbidity and mortality. Effective treatments for IPF are limited. Several recent studies have investigated novel therapeutic agents for IPF, but very few have addressed their comparative benefits an...

Descripción completa

Detalles Bibliográficos
Autores principales: Rochwerg, Bram, Neupane, Binod, Zhang, Yuan, Garcia, Carlos Cuello, Raghu, Ganesh, Richeldi, Luca, Brozek, Jan, Beyene, Joseph, Schünemann, Holger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741055/
https://www.ncbi.nlm.nih.gov/pubmed/26843176
http://dx.doi.org/10.1186/s12916-016-0558-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741055/
https://www.ncbi.nlm.nih.gov/pubmed/26843176
http://dx.doi.org/10.1186/s12916-016-0558-x

Ejemplares similares